Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Feb 08, 2024 | |||||||
GSE246660 |
LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
|
8 | Stefan Ambs | Feb 08, 2024 | ||||
GSE253234 |
Lung epithelium releases growth differentiation factor 15 in response to pathogen-mediated injury
|
10 | William Bain | Feb 08, 2024 | ||||
GSE242754 |
RNAseq of human tissue culture cells following treatment with MIR-28 family microRNA mimics
|
18 | Carson Bryant | Feb 08, 2024 | ||||
GSE242755 |
miR-eCLIP of MCF10A cells following treatment with MIR-28 family microRNA mimics
|
2 | Carson Bryant | Feb 08, 2024 | ||||
GSE250206 |
Coactivator condensation drives cell lineage specification
|
30 | kenian chen | Feb 08, 2024 | ||||
GSE232225 |
Characterizing Pneumocystis carinii centromeres with ChIP-seq III
|
3 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE232355 |
Characterizing Pneumocystis carinii centromeres with ChIP-seq (pc_210927)
|
8 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE232357 |
Characterizing Pneumocystis carinii centromeres with ChIP-seq (pc_210506)
|
4 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE232453 |
Characterizing Pneumocystis carinii centromeres with ChIP-seq (pm_211220)
|
5 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE232454 |
Characterizing Pneumocystis murina centromeres with ChIP-seq (pm_191010)
|
3 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE255176 |
DNA methylation analysis in Pneumocystis carinii using bisulfite sequencing
|
1 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE255235 |
RNA-seq analysis of Pneumocystis murina in short term culture
|
3 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE255275 |
Regional Centromere Configuration in the Fungal Pathogens of Pneumocystis Genus
|
35 | Ousmane Hamadoun Cisse | Feb 08, 2024 | ||||
GSE255117 |
Multiplexed Assays of Variant Effects (MAVE) of PALB2 single nucleotide variants in exon 10.
|
6 | Fergus Couch | Feb 08, 2024 | ||||
GSE242134 |
fhl2b expression ameliorates muscular dystrophy [20 months EOM and trunk]
|
12 | Nils Dennhag | Feb 08, 2024 | ||||
GSE242135 |
fhl2b expression ameliorates muscular dystrophy [5dpf trunk]
|
16 | Nils Dennhag | Feb 08, 2024 | ||||
GSE242136 |
fhl2b expression ameliorates muscular dystrophy [5 months EOM and trunk]
|
12 | Nils Dennhag | Feb 08, 2024 | ||||
GSE242137 |
fhl2b expression ameliorates muscular dystrophy
|
40 | Nils Dennhag | Feb 08, 2024 | ||||
GSE224131 |
Transcriptional effects of siRNA-mediated MAFB knockdown on SARS-CoV-2-infected human M-CSF and GM-derived macrophages.
|
24 | Angeles Domínguez Soto | Feb 08, 2024 | ||||
GSE224845 |
Transcriptional effects of SARS-CoV-2 and their VLPs (virus-like particles) on human GM-CSF-derived macrophages
|
36 | Angeles Domínguez Soto | Feb 08, 2024 |